- Biotech
company is focused on becoming a worldwide leader in R&D and sale of
hemp-derived, CBD-based nutraceuticals, pharmaceuticals and dietary
supplements
- ETST
is developing three new CBD formulas in Canada under a provisory patent;
it is also clinical testing its Hygee medical device for detecting
sexually transmitted diseases in women
- With
its Form 10 Registration Statement filing now effective, ETST will begin
reporting annual, quarterly and periodic financial statements
Earth Science Tech, Inc. (OTCQB: ETST) anticipates that its
uplisting to the OTCQB Venture Market will enable it to reach global
recognition and increase liquidity as a leader in the hemp-based CBD space in
several fields, such as cannabinoid products. It also develops innovative
medical devices designed for multi-national marketing (http://ibn.fm/IArhk).
The Florida-based company seeks to raise its recognition
level and perform more R&D for the CBD industry. ETST manufactures, markets
and distributes its own cannabinoid products, including capsules and oils. It
is a leader in the medical cannabis markets, with its products available at
retail health food stores and e-liquid smoke shops.
“Historically, up-listing to the OTCQB and being fully
reporting has resulted in greater liquidity and awareness,” Nickolas S.
Tabraue, president, director and chairman of ETST, stated in a news
release (http://ibn.fm/kFLuV).
“We are committed to the higher level of corporate and financial disclosures
required as an OTCQB fully reporting company, demonstrating our commitment to
our loyal shareholders.”
In Canada, it is testing three new CBD IP formulations. It
is also clinical testing its Hygee MSN-2 medical device for detection of
sexually transmitted infections (STIs) in women at Québec’s Clinique Santé
Amitié (http://ibn.fm/BGONO).
It is developing two new products in Brazil in a joint
venture with Bionatus Laboratrio Botnico of Brazil and its Canadian division
Bionatus Botanical Laboratories, Inc. In the U.S., it is conducting studies
with the University of Central Oklahoma on the impact of high grade full
spectrum CBD on immune cells and breast cancer (http://ibn.fm/WvDDW).
ETST holds several wholly owned subsidiaries. Cannabis
Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures
and distributes in the recreational sector. Earth Science Foundation, Inc. is
becoming a non-profit and accepts grants and donations to conduct additional
studies. Earth Science Pharmaceutical develops medical diagnostic tools and
vaccines. It also formed subsidiary Canno Inno Laboratories Inc., a strategic
Montreal, Canada-based company that provides ETST with access to government
grants.
For more information, visit the company’s website at www.EarthScienceTech.com
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
